Following this subscription, ImmuPharma will hold 9,904,319 shares in Incanthera, representing a 15.35% position in the enlarged share capital of Incanthera.
Welshfalcon, One always has to see the reality and not just what we would like to see ... I have great confidence in Synairgen and their directors and there is absolutely no deramping from me . I do believe however that they should have put the financial consequences of the Map issue in the RNS ... full stop
Sng will be paying all the costs and will not be receiving any income from the Map but they will be getting feedback which will help when filing for EU , imo
Immupharma have now ´invested ´ 2million 250 k into Tim's other company Incanthera .... We shareholders of Immupharma have been majorly diluted to fund this ´ investment ´ I would hope that we will reap some benefits in the long term from this participation but only time will tell ....